SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARONI, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.549
AS - Asia 3.131
EU - Europa 1.770
SA - Sud America 506
AF - Africa 64
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.385
SG - Singapore 1.183
CN - Cina 737
IT - Italia 480
VN - Vietnam 401
BR - Brasile 376
DE - Germania 309
HK - Hong Kong 233
GB - Regno Unito 195
UA - Ucraina 174
TR - Turchia 119
BD - Bangladesh 105
PL - Polonia 97
JP - Giappone 95
FR - Francia 94
CA - Canada 89
FI - Finlandia 89
RU - Federazione Russa 73
SE - Svezia 71
IN - India 57
MX - Messico 55
ID - Indonesia 52
AR - Argentina 45
NL - Olanda 37
ES - Italia 34
BE - Belgio 30
IQ - Iraq 29
ZA - Sudafrica 27
EC - Ecuador 26
PK - Pakistan 21
CZ - Repubblica Ceca 19
CO - Colombia 16
AT - Austria 15
MA - Marocco 14
AU - Australia 13
PE - Perù 13
LT - Lituania 12
MY - Malesia 12
UZ - Uzbekistan 11
VE - Venezuela 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
KE - Kenya 7
PH - Filippine 7
IE - Irlanda 6
RO - Romania 6
JO - Giordania 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
ET - Etiopia 4
GE - Georgia 4
IL - Israele 4
JM - Giamaica 4
PS - Palestinian Territory 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
GT - Guatemala 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MK - Macedonia 1
Totale 11.030
Salva come PNG Salva come JPEG
Città #
Singapore 751
Ashburn 629
San Jose 394
Fairfield 383
Woodbridge 361
Chandler 274
Beijing 256
Santa Clara 240
Hong Kong 226
Dallas 216
Houston 215
Ferrara 192
Ann Arbor 190
Seattle 169
Jacksonville 168
Wilmington 153
Ho Chi Minh City 132
Cambridge 123
New York 121
The Dalles 105
Los Angeles 97
Munich 93
Warsaw 91
Tokyo 89
Hanoi 84
Boardman 77
Izmir 66
Council Bluffs 62
Milan 61
Nanjing 59
Princeton 56
Lauterbourg 52
Orem 45
Jakarta 42
Shanghai 41
São Paulo 41
Dearborn 37
Mexico City 37
Bremen 32
Helsinki 32
San Diego 32
Brooklyn 27
Montreal 26
Brussels 25
Falls Church 23
Shenyang 23
Denver 22
Haiphong 22
Manchester 22
Nanchang 22
Toronto 22
Turku 22
Chicago 21
Da Nang 21
Hefei 21
Rome 21
London 20
Buffalo 19
Johannesburg 19
Moscow 19
Guangzhou 18
Poplar 18
Florence 17
Frankfurt am Main 17
Brno 16
Redwood City 16
Amsterdam 15
Hebei 14
Norwalk 14
Phoenix 14
Tianjin 14
Boston 13
Dong Ket 13
Biên Hòa 12
Chennai 12
Jiaxing 12
Atlanta 11
Bologna 11
Mcallen 11
Mumbai 11
San Francisco 11
Verona 11
Baghdad 10
Columbus 10
Tashkent 10
Zhengzhou 10
Düsseldorf 9
Quito 9
San Mateo 9
Hải Dương 8
Montréal 8
Rio de Janeiro 8
Stockholm 8
Auburn Hills 7
Augusta 7
Baku 7
Belo Horizonte 7
Can Tho 7
Des Moines 7
Dortmund 7
Totale 7.390
Salva come PNG Salva come JPEG
Nome #
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 286
Hemostasis biomarkers in multiple sclerosis 257
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 252
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 242
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 241
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 241
Membrane binding and anticoagulant properties of protein S natural variants 238
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 238
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 237
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 232
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 220
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 213
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 213
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 210
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 208
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 208
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 208
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 207
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 198
Plasma levels of soluble NCAM in multiple sclerosis 196
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 190
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 189
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 188
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 181
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 179
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 174
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 166
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 165
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 163
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 163
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 163
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 162
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 158
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 154
Hemostasis gene expression of the internal jugular and saphenous veins 152
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 151
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 150
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 149
Non-conventional therapeutic strategies for inherited disorders of hemostasis 148
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 147
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 146
THE NATURAL ARG386CYS MUTATION IN THE COAGULATION FACTOR X, AS A TOOL TO INVESTIGATE DIFFERENT FX-REQUIREMENTS IN INITIATION AND PROPAGATION PHASES. 140
West Nile virus non-structural protein 1 promotes amyloid Beta deposition and neurodegeneration 140
Tratamiento y profilaxis de trastornos cardiovasculares con ácido erúcico 139
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 137
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 137
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 129
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 128
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 122
Natural mutations in the EGF4 domain of protein S produce extended conformational changes and alter phospholipid and C4bBP interactions 121
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 118
The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII 117
NATURAL MUTATIONS IN THE EGF4 DOMAIN OF PROTEIN S PRODUCE EXTENDED CONFORMATIONAL CHANGES AND ALTER PHOSPHOLIPID AND C4BBP INTERACTIONS 116
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 114
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 110
Molecular characterization of factor X deficiency associated with borderline plasma factor X level 97
Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†) 95
null 94
null 93
Coagulation factor VII variants resistant to inhibitory antibodies. 93
Coagulation factor VII variants resistant to inhibitory antibodies 93
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 90
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis (P3.368) 86
Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping 84
null 84
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 73
null 73
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 66
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 65
Flavivirus Nonstructural Protein 1-Driven Coagulation via Tissue Factor-Bearing Microvesicles: A Pilot Study 57
null 56
null 45
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile 33
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions. 26
Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection 25
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile 16
Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease 15
Totale 11.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022636 84 70 22 28 24 29 26 35 18 49 44 207
2022/2023634 60 64 23 87 92 88 46 50 67 8 37 12
2023/2024436 27 33 15 10 32 64 22 48 12 16 10 147
2024/20251.565 33 41 143 47 170 153 33 61 254 210 235 185
2025/20265.041 491 249 476 626 756 331 580 247 428 539 297 21
Totale 11.210